BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Göbel T, Vorderwülbecke S, Hauck K, Fey H, Häussinger D, Erhardt A. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples. World J Gastroenterol 2006; 12(47): 7604-7612 [PMID: 17171788 DOI: 10.3748/wjg.v12.i47.7604] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Tessitore A, Gaggiano A, Cicciarelli G, Verzella D, Capece D, Fischietti M, Zazzeroni F, Alesse E. Serum biomarkers identification by mass spectrometry in high-mortality tumors. Int J Proteomics 2013;2013:125858. [PMID: 23401773 DOI: 10.1155/2013/125858] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
2 Husain H, Ahmad R, Khan A, Inamuddin, Asiri AM. Proteomic-genomic adjustments and their confluence for elucidation of pathways and networks during liver fibrosis. International Journal of Biological Macromolecules 2018;111:379-92. [DOI: 10.1016/j.ijbiomac.2017.12.168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Uto H, Kanmura S, Takami Y, Tsubouchi H. Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers. Proteome Sci 2010;8:70. [PMID: 21192835 DOI: 10.1186/1477-5956-8-70] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
4 Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Davidson B, Rodríguez-Perálvarez M, Mantzoukis K, O’Brien J, Thalassinos E, Papastergiou V. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-409, v-vi. [PMID: 25633908 DOI: 10.3310/hta19090] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 12.0] [Reference Citation Analysis]
5 Engwegen JY, Depla AC, Smits ME, Cats A, Tuynman H, van Heukelem HA, Snel P, Meuleman W, Wessels LF, Schellens JH, Beijnen JH. Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk. Biomark Insights 2008;3:375-85. [PMID: 19578519 DOI: 10.4137/bmi.s790] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Karpova MA, Moshkovskii SA, Toropygin IY, Archakov AI. Cancer-specific MALDI-TOF profiles of blood serum and plasma: biological meaning and perspectives. J Proteomics. 2010;73:537-551. [PMID: 19782778 DOI: 10.1016/j.jprot.2009.09.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
7 Theodorescu D, Mischak H. Mass spectrometry based proteomics in urine biomarker discovery. World J Urol 2007;25:435-43. [PMID: 17703310 DOI: 10.1007/s00345-007-0206-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
8 Hannivoort RA, Hernandez-Gea V, Friedman SL. Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair 2012;5:1. [PMID: 22214245 DOI: 10.1186/1755-1536-5-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
9 Henkel C, Schwamborn K, Zimmermann HW, Tacke F, Kühnen E, Odenthal M, Groseclose MR, Caprioli RM, Weiskirchen R. From proteomic multimarker profiling to interesting proteins: thymosin-β(4) and kininogen-1 as new potential biomarkers for inflammatory hepatic lesions. J Cell Mol Med 2011;15:2176-88. [PMID: 21496200 DOI: 10.1111/j.1582-4934.2010.01204.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
10 Mas VR, Maluf DG, Archer KJ, Yanek K, Bornstein K, Fisher RA. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation. Transplantation 2009;87:143-52. [PMID: 19136905 DOI: 10.1097/TP.0b013e318191c68d] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
11 Li S, Liu X, Wei L, Wang H, Zhang J, Wei H, Qian X, Jiang Y, He F. Plasma biomarker screening for liver fibrosis with the N-terminal isotope tagging strategy. Sci China Life Sci 2011;54:393-402. [PMID: 21574042 DOI: 10.1007/s11427-011-4165-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology. 2007;46:912-921. [PMID: 17705266 DOI: 10.1002/hep.21835] [Cited by in Crossref: 251] [Cited by in F6Publishing: 239] [Article Influence: 16.7] [Reference Citation Analysis]
13 Simula MP, De Re V. Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomics. Proteomics Clin Appl. 2010;4:782-793. [PMID: 21137022 DOI: 10.1002/prca.201000049] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
14 Bhopale KK, Amer SM, Kaphalia L, Soman KV, Wiktorowicz JE, Shakeel Ansari GA, Kaphalia BS. Proteomic Profiling of Liver and Plasma in Chronic Ethanol Feeding Model of Hepatic Alcohol Dehydrogenase-Deficient Deer Mice. Alcohol Clin Exp Res. 2017;41:1675-1685. [PMID: 28792616 DOI: 10.1111/acer.13470] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
15 Tammen H, Peck A, Budde P, Zucht H. Peptidomics analysis of human blood specimens for biomarker discovery. Expert Review of Molecular Diagnostics 2014;7:605-13. [DOI: 10.1586/14737159.7.5.605] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
16 Zhong L, Taylor D, Begg D, Whittington R. Biomarker discovery for ovine paratuberculosis (Johne's disease) by proteomic serum profiling. Comparative Immunology, Microbiology and Infectious Diseases 2011;34:315-26. [DOI: 10.1016/j.cimid.2011.03.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
17 Spano D, Cimmino F, Capasso M, D’angelo F, Zambrano N, Terracciano L, Iolascon A. Changes of the Hepatic Proteome in Hepatitis B-Infected Mouse Model at Early Stages of Fibrosis. J Proteome Res 2008;7:2642-53. [DOI: 10.1021/pr7006522] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
18 Ahmed FE. The role of capillary electrophoresis–mass spectrometry to proteome analysis and biomarker discovery. Journal of Chromatography B 2009;877:1963-81. [DOI: 10.1016/j.jchromb.2009.05.023] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
19 Takahara Y, Takahashi M, Zhang QW, Wagatsuma H, Mori M, Tamori A, Shiomi S, Nishiguchi S. Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients. World J Gastroenterol 2008; 14(13): 2010-2022 [PMID: 18395900 DOI: 10.3748/wjg.14.2010] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
20 Rye K, Scott R, Mortimore G, Lawson A, Austin A, Freeman J. Towards noninvasive detection of oesophageal varices. Int J Hepatol 2012;2012:343591. [PMID: 22506126 DOI: 10.1155/2012/343591] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
21 Shen SQ, Li K, Zhu N, Nakao A. Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma. Med Oncol 2008;25:341-5. [PMID: 18214716 DOI: 10.1007/s12032-008-9042-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
22 Zhang J, Guo F, Wang L, Zhao W, Zhang D, Yang H, Yu J, Niu L, Yang F, Zheng S, Wang J. Identification of apolipoprotein C-I as a potential Wilms' tumor marker after excluding inflammatory factors. Int J Mol Sci 2014;15:16186-95. [PMID: 25222555 DOI: 10.3390/ijms150916186] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
23 Lin Y, Dynan WS, Lee JR, Zhu ZH, Schade RR. The current state of proteomics in GI oncology. Dig Dis Sci 2009;54:431-57. [PMID: 19104933 DOI: 10.1007/s10620-008-0656-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
24 Ndao M, Rainczuk A, Rioux MC, Spithill TW, Ward BJ. Is SELDI-TOF a valid tool for diagnostic biomarkers? Trends Parasitol. 2010;26:561-567. [PMID: 20708969 DOI: 10.1016/j.pt.2010.07.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
25 Vivekanandan P, Singh OV. High-dimensional biology to comprehend hepatocellular carcinoma. Expert Rev Proteomics. 2008;5:45-60. [PMID: 18282123 DOI: 10.1586/14789450.5.1.45] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
26 Cheung KJ, Tilleman K, Deforce D, Colle I, Van Vlierberghe H. Proteomics in liver fibrosis is more than meets the eye: . European Journal of Gastroenterology & Hepatology 2008;20:450-64. [DOI: 10.1097/meg.0b013e3282f4de92] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Smith JO, Sterling RK. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2009;30:557-76. [DOI: 10.1111/j.1365-2036.2009.04062.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 6.6] [Reference Citation Analysis]
28 Kolusheva S, Yossef R, Kugel A, Hanin-Avraham N, Cohen M, Rubin E, Porgador A. A novel "reactomics" approach for cancer diagnostics. Sensors (Basel) 2012;12:5572-85. [PMID: 22778601 DOI: 10.3390/s120505572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
29 Roessler S, Budhu A, Wang XW. Future of molecular profiling of human hepatocellular carcinoma. Future Oncol. 2007;3:429-439. [PMID: 17661718 DOI: 10.2217/14796694.3.4.429] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
30 Fallatah HI. Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology 2014;2014:1-15. [DOI: 10.1155/2014/357287] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
31 Ibrahim MK, Salama H, Abd El Rahman M, Dawood RM, Bader El Din NG, Salem HF, Abdelrahim ME, Omran D, Omran MH, El-wakeel KH, Abdelhafez TH, Khedr A, El Awady MK. Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients. Journal of Interferon & Cytokine Research 2016;36:698-705. [DOI: 10.1089/jir.2016.0042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
32 Ndao M. Biomarker Discovery in Serum/Plasma Using Surface Enhanced Laser Desorption Ionization Time of Flight (SELDI–TOF) Mass Spectrometry. In: Clarke CH, Mccarthy DLB, editors. SELDI-TOF Mass Spectrometry. New York: Springer; 2012. pp. 67-79. [DOI: 10.1007/978-1-61779-418-6_5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
33 Hodgetts A, Levin M, Kroll JS, Langford PR. Biomarker discovery in infectious diseases using SELDI. Future Microbiology 2007;2:35-49. [DOI: 10.2217/17460913.2.1.35] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
34 Cohen M, Yossef R, Erez T, Kugel A, Welt M, Karpasas MM, Bones J, Rudd PM, Taieb J, Boissin H. Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays. PLoS One. 2011;6:e14540. [PMID: 21267442 DOI: 10.1371/journal.pone.0014540] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
35 Bell LN, Theodorakis JL, Vuppalanchi R, Saxena R, Bemis KG, Wang M, Chalasani N. Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology. 2010;51:111-120. [PMID: 19885878 DOI: 10.1002/hep.23271] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 7.3] [Reference Citation Analysis]
36 Cowan ML, Rahman TM, Krishna S. Proteomic approaches in the search for biomarkers of liver fibrosis. Trends Mol Med. 2010;16:171-183. [PMID: 20304704 DOI: 10.1016/j.molmed.2010.01.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]